Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001788965 | SCV002030208 | uncertain significance | Fanconi anemia complementation group G | 2021-01-26 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Sema4, |
RCV002258311 | SCV002537558 | uncertain significance | Fanconi anemia | 2021-06-18 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV001788965 | SCV002782680 | uncertain significance | Fanconi anemia complementation group G | 2021-07-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002258311 | SCV003783687 | uncertain significance | Fanconi anemia | 2022-06-27 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 257 of the FANCG protein (p.Arg257Cys). This variant is present in population databases (rs759314410, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with FANCG-related conditions. ClinVar contains an entry for this variant (Variation ID: 1327085). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |